Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE2A | O00408 | 7/20 | 0.63 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.42 |
| ▸ | EEF2K | O00418 | 1/20 | 0.41 |
| ▸ | MRGPRX4 | Q96LA9 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | CES2 | O00748 | 1/20 | 0.40 |
| ▸ | CES1 | P23141 | 1/20 | 0.40 |
| ▸ | PPARG | P37231 | 3/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4633442 | 1.00 | PDE2A (0.63) | PDE2AFFAR1CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL16829661 | 0.87 | PDE2A (0.50) | PDE2AFFAR1MRGPRX4KDM4EALDH1A1 | |
| SCHEMBL7823148 | 0.83 | PDE2A (0.63) | PDE2AFFAR1CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL6702844 | 0.81 | CES2 (0.51) | PDE2AKDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL6681467 | 0.81 | CES2 (0.51) | PDE2AKDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL8974847 | 0.81 | PDE2A (0.60) | PDE2AKDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL8974843 | 0.81 | PDE2A (0.60) | PDE2AKDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL6676167 | 0.81 | PDE2A (0.47) | PDE2ACYP1A2CYP2C19KDM4EALDH1A1 | |
| SCHEMBL6681459 | 0.81 | CES2 (0.51) | PDE2AKDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL6679457 | 0.78 | CES2 (0.51) | PDE2AKDM4EALDH1A1HPGDHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080311636-A1 | Method for Producing Optically Active Alpha-Hydroxycarboxylic Acid | DAIICHI FINE CHEMICAL CO., LTD. (JP) | 2008-12-18 | — | — | US | disclosed |
| EP-1930441-A1 | METHOD FOR PRODUCTION OF OPTICALLY ACTIVE -HYDROXYCARBOXYLIC ACID | Daiichi Fine Chemical Co., Ltd. (JP) | 2008-06-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080311636-A1 | Method for Producing Optically Active Alpha-Hydroxycarboxylic Acid | PCCA, HCAR1, HCAR2 | PDE2A 3917/4885FFAR1 613/4885CYP1A2 1097/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.